PHARMACOKINETICS OF CIPROFLOXACIN IN THE ELDERLY - INCREASED ORAL BIOAVAILABILITY AND REDUCED RENAL CLEARANCE

被引：27

作者：

LJUNGBERG, B

NILSSONEHLE, I

机构：

来源：

关键词：

D O I：

10.1007/BF01967470

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：515 / 520

页数：6

共 25 条

[11] EASMON CSF, 1988, QUINOLONES B, V4, P11
[12] Gibaldi M., 1984, BIOPHARMACEUTICS CLI, P17
[13] REFERENCE VALUES FOR CR-51-EDTA CLEARANCE AS A MEASURE OF GLOMERULAR-FILTRATION RATE
GRANERUS, G
AURELL, M
[J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1981, 41 (06) : 611 - 616
[14] PHARMACOKINETICS OF CIPROFLOXACIN AFTER ORAL AND PARENTERAL ADMINISTRATION
HOFFKEN, G
LODE, H
PRINZING, C
BORNER, K
KOEPPE, P
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (03) : 375 - 379
[15] KLEIN U, 1976, INT J CLIN PHARM BI, V13, P187
[16] KRUTZEN E, 1984, J LAB CLIN MED, V104, P955
[17] LEBEL M, 1987, AM J MED, V82, P108
[18] LEBEL M, 1986, PHARMACOTHERAPY, V6, P87
[19] TISSUE PENETRATION OF CIPROFLOXACIN AFTER SINGLE AND MULTIPLE DOSES
LEBEL, M
VALLEE, F
BERGERON, MG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) : 501 - 505
[20] LJUNGBERG B, 1987, REV INFECT DIS, V9, P250